[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Park et al., 2020 - Google Patents

Synthesis and characterization of polyfumarateurethane nanoparticles for sustained release of bupivacaine

Park et al., 2020

View HTML
Document ID
9666131257353191337
Author
Park S
Kang J
Yoon J
Chung I
Publication year
Publication venue
Pharmaceutics

External Links

Snippet

Biodegradable polyfumarateurethane (PFU) for use as a bupivacaine delivery vehicle, synthesized using di-(2-hydroxypropyl fumarate)(DHPF), polyethylene glycol (PEG) and 1, 6- hexamethylene diisocyanate (HMDI), was designed to be degradable through the hydrolysis …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30—Macromolecular compounds
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, copolymers of polyalkylene glycol or poloxamer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/91—Polymers modified by chemical after-treatment
    • C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids

Similar Documents

Publication Publication Date Title
Li et al. Synthesis and biological application of polylactic acid
Tan et al. PH responsive polyurethane for the advancement of biomedical and drug delivery
Urbánek et al. Selectively biodegradable polyesters: Nature-inspired construction materials for future biomedical applications
Prakash et al. Advances in polyhydroxyalkanoate nanocarriers for effective drug delivery: An overview and challenges
Chan et al. Poly (carbonate urethane)-based thermogels with enhanced drug release efficacy for chemotherapeutic applications
Rey-Rico et al. Supramolecular cyclodextrin-based hydrogels for controlled gene delivery
Hsu et al. Nanoparticle-hydrogel composite drug delivery system for potential ocular applications
Bhadran et al. Recent advances in polycaprolactones for anticancer drug delivery
Vlakh et al. Preparation, characterization, and biological evaluation of poly (glutamic acid)-b-polyphenylalanine polymersomes
Sobczak et al. Biomedical polyurethanes for anti-cancer drug delivery systems: A brief, comprehensive review
Kim et al. Light-responsive polymeric micellar nanoparticles with enhanced formulation stability
Kundrat et al. Drug release kinetics of electrospun PHB meshes
Hyun et al. Thermo-responsive injectable MPEG-polyester diblock copolymers for sustained drug release
Rodríguez-Cendal et al. Biomedical applications of the biopolymer poly (3-hydroxybutyrate-co-3-hydroxyvalerate)(PHBV): drug encapsulation and scaffold fabrication
Guadagno et al. Electrospun membranes designed for burst release of new gold-complexes inducing apoptosis of melanoma cells
Pan et al. Chitosan-based self-healing hydrogel: from fabrication to biomedical application
Christodoulou et al. Branched poly (ε-caprolactone)-based copolyesters of different architectures and their use in the preparation of anticancer drug-loaded nanoparticles
Feng et al. Stereocomplex-reinforced PEGylated polylactide micelle for optimized drug delivery
Yoon et al. In vitro and in vivo biosafety analysis of resorbable polyglycolic acid-polylactic acid block copolymer composites for spinal fixation
Ahmad Shariff et al. Poly (caprolactone)-b-poly (ethylene glycol)-based polymeric micelles as drug carriers for efficient breast cancer therapy: a systematic review
Ferrentino et al. Poly (ε-caprolactone)-poly (ethylene glycol) Tri-Block Copolymer as Quercetin Delivery System for Human Colorectal Carcinoma Cells: Synthesis, Characterization and In Vitro Study
Stepanova et al. Aminated graphene-graft-oligo (glutamic acid)/poly (ε-caprolactone) composites: Preparation, characterization and biological evaluation
Karava et al. Poly (L-lactic acid)-co-poly (butylene adipate) new block copolymers for the preparation of drug-loaded long acting injectable microparticles
Han et al. Electrospun hyaluronan nanofiber membrane immobilizing aromatic doxorubicin as therapeutic and regenerative biomaterial
du Toit et al. An injectable nano-enabled thermogel to attain controlled delivery of p11 peptide for the potential treatment of ocular angiogenic disorders of the posterior segment